South Africa crush India by 135 runs, win series

Agencies
January 17, 2018

Centurion, Jan 17: Indomitable at home, India's batsmen capitulated in the face of South Africa's menacing pace attack to suffer a 135-run drubbing in the second Test here today, ending a nine-series unbeaten run for Virat Kohli's world No.1 side.

After the 72-run loss in the opening Test, the margin got bigger here as the visitors handed the home side a 2-0 lead in the three-match series.

Rohit Sharma's 47 was the lone noteworthy contribution in a chase of 287, which was a tall ask from the beginning given the unpredictable bounce of the pitch. The Indians folded for 151 in 50.2 overs, never really offering a fight.

It was a revenge of sorts for Faf du Plessis' side, which had been blanked 3-0 by hosts India in 2015.

Debutant Lungi Ngidi was the newest fast-bowling nemesis that India discovered as he snared six scalps for a mere 39 runs in 12.2 overs.

From team selection to shot selection, to running between the wickets to the absence of sheer grit, India were left pondering quite a few issues at the end of just there second Test away from the sub-continent in more than a year.

Ngidi became the sixth Proteas' pacer to pick a five- wicket haul in his debut Test after Lance Klusener (8/62 vs India in 1996), Charles Langeveldt (5/46 vs England in 2005), Vernon Philander (5/15 vs Australia in 2011), Merchant de Lange (7/81 vs Sri Lanka in 2011) and Kyle Abbott (7/29 vs Pakistan in 2013).

This was after India, had been reduced to 87/7 at one stage, looking firmly down the barrel.

Starting from overnight 35/3, it was another horrific first hour of play for the visitors.

On the 19th ball of the morning, in the 27th over, Cheteshwar Pujara (19) was run out for the second time in the match. He went for an unnecessary third run and couldn't beat AB de Villiers' throw from the deep, which Quinton de Kock swiftly passed to the stumps.

After his suicidal run-out in the first innings, Pujara became the first Indian batsman to be run-out twice in the same Test.

Three overs later, Parthiv Patel (19) pulled Kagiso Rabada (3-47) and a flying Morne Morkel took a brilliant catch at the deep square leg boundary.

Hardik Pandya (6) added 18 runs with Rohit (47 runs, 74 balls, 6 fours, 1 six). But then played a poor stroke off Ngidi in an attempt to lift the ball over slip cordon.

Instead, Pandya was caught behind leaving India at 83/6.

Ten balls later, R Ashwin (3) was caught behind off Ngidi and India's hopes to even salvage a draw lay in tatters.

Mohammed Shami (28 runs, 24 balls, 5 fours) though provided a ray of hope. He put on 54 runs off 61 balls with Rohit for the eighth wicket. In doing so, the duo pushed India past 100 in the 39th over.

Just ahead of the scheduled lunch break, in the 48th over, Rohit was caught in the deep off Rabada as the morning session was extended.

Six balls later, Ngidi then returned to pick up his fifth wicket as Shami's mistimed pull shot was caught at mid-on.

Two overs later, the burly pacer also accounted for Jasprit Bumrah (2) and subjected India to an embarrassing loss.

Ishant Sharma (4) was the last man standing for the visitors, who will have quite a few matters to resolve before the third and final Test in Johannesburg, which starts on January 24.

The debacle is Kohli's first as full-time captain even though he did well with the bat in this match, scoring 153 in the first innings.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 4,2020

Tokyo, Mar 4: Takeda Pharmaceutical Co said on Wednesday it was developing a drug to treat COVID-19, the flu-like illness that has struck more than 90,000 people worldwide and killed over 3,000.

The Japanese drugmaker is working on a plasma-derived therapy to treat high-risk individuals infected with the new coronavirus and will share its plans with members of the U.S. Congress on Wednesday, it said in a statement.

Takeda is also studying whether its currently marketed and pipeline products may be effective treatments for infected patients.

"We will do all that we can to address the novel coronavirus threat...(and) are hopeful that we can expand the treatment options," Rajeev Venkayya, president of Takeda's vaccine business, said in the statement.

Takeda said it was in talks with various health and regulatory agencies and healthcare partners in the United States, Asia and Europe to move forward its research into the drug.

Its research requires access to the blood of people who have recovered from the respiratory disease or who have been vaccinated, once a vaccine is developed, Takeda said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 18,2020

Dubai, Mar 18: Emirates, one of the world's biggest international airlines, has asked pilots to take unpaid leave to help it mitigate the impact of the coronavirus pandemic that has shattered demand for global travel.

"To this end you are strongly encouraged to make use of this opportunity to volunteer for additional paid and unpaid leave," the airline said in an internal email to pilots, seen by Reuters.

Emirates earlier this month asked some staff to take unpaid leave, although at that time it was not available to pilots.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 16,2020

New Delhi, Jun 16: With an increase of 10,667 cases and 380 deaths in the past 24 hours, the COVID-19 count in India has reached 3,43,091 on Tuesday, according to the Union Health and Family Welfare Ministry.

It is noteworthy that today's spike in cases is lower than the 11,502 registered in the country yesterday and has also stayed below the 11 thousand mark it had been crossing for the past two days in a row.

However, there is an increase in the number of deaths due to the infection from yesterday, with 380 deaths being reported from across the country, the toll due to COVID-19 has now reached 9,900.

The COVID-19 count includes 1,53,178 active cases, while 1,80,013 patients have been cured and discharged or migrated so far.

Maharashtra with 1,10,744 cases continues to be the worst-affected state in the country with 50,567 active cases while 56,049 patients have been cured and discharged in the state so far. The toll due to COVID-19 has crossed the four thousand mark and reached 4,128 in the state.
It is followed by Tamil Nadu with 46,504 and the national capital with 42,829 confirmed cases.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.